Despite considerable progress has been achieved in the treatment of acute myeloid
leukemia over the past decades, relapse remains a major problem. Novel therapeutic …

ABSTRACT CD47 is a ubiquitously expressed cell surface glycoprotein that functions as a
signaling receptor for thrombospondin-1 and as the counter-receptor for signal regulatory …

Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast
cancer. Radiation therapy (RT) is a modality for TNBC management. Radiosensitizers can …

CD47 performs a vital function in cancer therapy by binding to different SIRPα,
thrombospondin 1, and integrin. However, its role in tumor immunity and its correlation with …

Lymphoma is a name for malignant diseases of the lymphatic system including Hodgkin's
lymphoma and non‐Hodgkin's lymphoma. Although several approaches are used for the …

Natural killer (NK) cells are a predominant part of innate immune cells and play a crucial role
in anti-cancer immunity. NK cells can kill target cells nonspecifically, and their recognition of …

Natural killer (NK) cells are essential for the elimination of the transformed and cancerous
cells. Killer cell immunoglobulin-like receptors (KIRs) which expressed by T and NK cells …

Natural killer (NK) cells, the primary effector cells of the innate immune system, utilize
multiple strategies to recognize tumor cells by (1) detecting the presence of activating …

Immunotherapy is an emerging form of cancer therapy that is associated with promising
outcomes. However, most cancer patients either do not respond to immunotherapy or …

Induction of immunogenic cell death (ICD) is a promising strategy for cancer
immunotherapy. Chrysin, which has potential anticancer effects, faces limitations in clinical …